Company Overview and News
Predictive Discovery Ltd (ASX:PDI) has received test work and drilling results from its Bira gold prospect within the Burkina Faso joint venture with Progress Minerals International.
Predictive Discovery Ltd’s (ASX:PDI) is mainly targeting gold ore resources in West Africa, an area that appeals to management given its history of delivering large resources.
Predictive Discovery Ltd (ASX:PDI) has tripled the length of the gold mineralised zone at Bira prospect, which is part of the Eastern Burkina Faso Joint Venture with Progress Minerals International.
Predictive Discovery Ltd. (ASX:PDI) managing director Paul Roberts tells Proactive Investors that RC drilling results are expected out in the next few weeks for both the Bira Project in Burkina Faso and Ferkessedougou North in Côte d’Ivoire.
Predictive Discovery Ltd (ASX:PDI) has substantially expanded its ground position north of the Nyangboue gold discovery in the Toro Gold Joint Venture in Cote D’Ivoire.
Paul Roberts, Managing Director of gold project generator Predictive Discovery (ASX:PDI), details expanding operations in West Africa. The company is now undertaking reconnaissance field work spanning 250 square kilometres in southern Mali under three exploration authorisations, to add to its more developed project pipeline in Burkina Faso and Cote D’Ivoire.
Predictive Discovery Ltd (ASX:PDI) has been granted three exploration authorisations covering 250 square kilometres in southern Mali.
Predictive Discovery Ltd (ASX:PDI) has received initial drill results from an ongoing 5,000-metre reverse circulation (RC) drill program on the Bira prospect within the Burkina Faso Joint Venture.
Predictive Discovery Ltd (ASX:PDI) has received the final batch of drill results from its Bobosso Joint Venture Project in Cote D’Ivoire.
Predictive Discovery Ltd (ASX:PDI) aims to boost its West African gold prospects through new drilling programs at two joint venture projects.
Predictive Discovery Ltd (ASX:PDI) has received assay results from 29 holes across four prospects at the Bobosso Project in Cote D’Ivoire.
Predictive Discovery Ltd (ASX:PDI) has commenced a large power auger drilling at its Burkina Faso gold projects held in joint venture with Progress Minerals International Inc.
Predictive Discovery Ltd (ASX:PDI) has commenced a 4,000-metre program of trenching at the Ferkessedougou North permit, a 17-kilometre long gold-in-soil anomaly located in Cote D’Ivoire.
Predictive Discovery Ltd's (ASX:PDI) managing director, Paul Roberts, has increased his stake in the company through participation in the heavily-oversubscribed renounceable rights issue.
Subscriptions were received under the rights issue for a total of 17.3 million new shares, resulting in a shortfall of 44.8 million shares.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...